Afatinib Dimaleate Intermedia CAS 314771-76-1 Puritas >99.0% (HPLC) Factory

Description:

Chemical Name: (S)-N4-(3-Chloro-4-Fluorophenyl) -7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine

CAS: 314771-76-1

Puritas: >99.0% (HPLC)

Aspectus: lux Yellow ad Yellow pulverem

Afatinib Dimaleate (CAS: 850140-73-7)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum (S)-N4-(3-Chloro-4-Fluorophenyl) -7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine
Synonyma N4-(3-Chloro-4-Fluorophenyl) -7-[[(3S)-Tetrahydro-3-Furanyl]oxy] -4,6-Quinazolinediamine;Afatinib immunditia B;Afatinib-des(4-Dimethylamino-2-en-1-oxo)butyl;Des(4-Dimethylamino-2-en-1-oxo)butyl Afatinib
CAS Number 314771-76-1
CATTUS Number RF-PI2028
Stock Status In Stock, Productio Capacitas 100MT/Annus
Formulae hypotheticae C18H16ClFN4O2
M. Pondus 374.8
Ferveret 559.0±50.0℃
Density 1.473±0.060 g/cm3
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Lux Yellow ad Yellow pulverem
Lepidium sativum In retentione Time of principalis Pecco in HPLC debet respondere ad vexillum
Puritas / Analysis Methodus >99.0% (HPLC)
Damnum in Siccatio <0.50%
Residere in Ignition <0.20%
una immunditia <0.50%
Totalis immunditias <1.00%
Metalla gravia (ut Pb) ≤20ppm
Test Standard Enterprise Standard
Consuetudinem Afatinib Dimaleate (CAS: 850140-73-7)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

(S)-N4-(3-Chloro-4-Fluorophenyl) -7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine (CAS: 314771-76-1) medium est ex Afatinib Dimaleate (CAS: 850140-73-7).Afatinib est secundae-generatio potentis et immedicabilis dualis inhibitoris incrementi epidermalis factoris receptoris (EGFR) et factoris incrementi humani epidermalis receptoris 2 (HER2) kinasis tyrosinae, a Boehringer Ingelheim, Germania evoluta.Capax est irreversibiliter inhibere activitates tyrosinae kinasi Michaelem reactionem cum thiol coetus cysteini in positione 797 EGFR subeundo.Munus: 1. Sicut Lapatinib et Neratinib, Afatinib est interdum inhibitor kinasus qui etiam irrevocabiliter impedit factorem 2 (Her2) et factor incrementi epidermalis receptoris (EGFR) kinases.2. Afatinib non solum activum contra mutationes EGFR iaculis a generatione prima TKIs sicut erlotinib vel gefitinib, sed etiam contra mutationes ut T790M quae ad has therapias normas non sentiuntur.Propter additam actionem contra Her2, investigatur pro carcinomate pectoris necnon aliis EGFR et Her2 carcinomata agitata.3. Afatinib medicamentum est curationi primae lineae aegris cum distinctis generibus metastaticorum (EGFR mutationem positivam) non parvam cellula pulmonis carcinoma (NSCLC).Agit inhibitor irreversibilis covalentis receptae tyrosinae kinases epidermalis aucti factoris receptoris (EGFR) et erbB-2 (HER2).

Epistulam tuam hic scribe et mitte nobis